SignalPoint Asset Management’s Gilead Sciences GILD Stock Holding History

SignalPoint Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,827	Closed	-$274K	–	169
2016 Q4	$274K	Sell	3,827 -494	-11%	-$36.7K	0.07%	213
2016 Q3	$342K	Buy	4,321 +109	+3%	+$8.85K	0.09%	167
2016 Q2	$351K	Buy	4,212 +302	+8%	+$26.8K	0.15%	153
2016 Q1	$359K	Buy	3,910 +169	+5%	+$15.2K	0.15%	139
2015 Q4	$379K	Buy	3,741 +377	+11%	+$39.2K	0.17%	110
2015 Q3	$330K	Sell	3,364 -102	-3%	-$11.3K	0.15%	114
2015 Q2	$340K	Hold	3,466	–	–	0.14%	126
2015 Q1	$340K	Buy	3,466 +1,103	+47%	+$112K	0.14%	126
2014 Q4	$223K	Buy	+2,363	New	+$244K	0.1%	149

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

SignalPoint Asset Management's GILD Position: Q1 2017 in Review

SignalPoint Asset Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 3,827 shares — an estimated $274K sold.

SignalPoint Asset Management first reported a position in GILD in Q4 2014 and held it in 9 quarters. The position peaked at $379K in Q4 2015. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

SignalPoint Asset Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
SignalPoint Asset Management sold 3,827 Gilead Sciences shares in Q1 2017, an estimated $274K.
SignalPoint Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 9 quarters.
SignalPoint Asset Management's Gilead Sciences position peaked at $379K in Q4 2015.
1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on SignalPoint Asset Management's 13F filing for Q1 2017, filed 2 May 2017.